Aubrey Inc (Carlsbad, CA) announced that after a successful soft release and product evaluation phase of its second-generation product, AWBAT® Plus, it is now in full production and are currently available for purchase. Hand burns are common injuries and complex wounds to treat. The AWBAT Plus Glove was designed specifically for ease of application and form fit, and to promote early mobility and rehabilitation, which is essential for maintaining functional dexterity and faster return to work. Founder Aubrey Woodroof, PhD MBA, expresses his appreciation for being able to advance the art once again. Renowned surgeons agree that the product has the potential to take wound coverage to the next level and that it provides not only an optimal milieu but also a stimulus to promote active wound healing. AWBAT Plus utilizes the same patented technology for the precision-porous silicone-nylon membrane as the platform product, AWBAT®. AWBAT Plus, however, contains significantly more collagen but also chondroitin-4-sulfate, chondroitin-6-sulfate, vitamin C, vitamin E, and Immuno-10 (activated mixture of polysaccharides from Aloe). It was determined by FDA to be a combination product consisting of device components as well as drugs. In subsequent laboratory testing, Immuno-10 was found to stimulate human dermal fibroblast proliferation, as well as fibroblast collagen and alpha-SMA production. Human keratinocyte production was also enhanced by Immuno-10. AWBAT Plus is currently indicated for partial–thickness burns, meshed autografts, and donor sites. The company intends to seek clearance for use of the product on chronic wounds this year.
Visit www.aubreyinc.com  for more information.